Zevra Therapeutics (ZVRA) Other Non-Current Liabilities (2014 - 2026)
Zevra Therapeutics' Other Liabilities was $17.89 million in Q3 2026, down 49.2% from $35.23 million a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Other Liabilities at Zevra Therapeutics came in at $18.32 million, down 50.3% from FY2024.
- Other Liabilities shows a five-year compound annual growth rate of 110.0% (FY2020 to FY2025).
- In earlier years, Other Liabilities was $36.87 million in FY2024 (+56.5%), $23.56 million in FY2023 (+130.4%), $10.23 million in FY2022 and $361,000 in FY2021 (-19.6%).
- Quarterly Other Liabilities has moved between $61,000 (Q3 2022) and $36.87 million (Q4 2024) over five years.
- Compared with a year earlier, Other Liabilities has declined for four straight quarters, with growth averaging 20.8% over the last eight quarters.
- The best year-over-year quarter for Other Liabilities over five years was Q3 2023 (growth of 588.5%); the worst was Q2 2022 (a decline of 89.0%).
- Per Business Quant data, ZVRA's Other Liabilities in the three quarters before Q3 2026 was $22.46 million (Q2 2026), $15.53 million (Q1 2026) and $18.32 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.89 Mn |
| Jun 30, 2026 | 22.46 Mn |
| Mar 31, 2026 | 15.53 Mn |
| Dec 31, 2025 | 18.32 Mn |
| Sep 30, 2025 | 35.23 Mn |
| Jun 30, 2025 | 36.60 Mn |
| Mar 31, 2025 | 34.07 Mn |
| Dec 31, 2024 | 36.87 Mn |
| Sep 30, 2024 | 19.42 Mn |
| Jun 30, 2024 | 14.54 Mn |
| Mar 31, 2024 | 20.07 Mn |
| Dec 31, 2023 | 23.56 Mn |
| Sep 30, 2023 | 420,000.00 |
| Jun 30, 2023 | 317,000.00 |
| Mar 31, 2023 | 161,000.00 |
| Dec 31, 2022 | 10.23 Mn |
| Sep 30, 2022 | 61,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 361,000.00 |
API Access
Zevra Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();